Hematology/Oncology Division

Research output

Research output per year 1981 2008 2010 2011 2012 2013 2014 2015 2016 2018 2019 2020 2021 2022 2025

• 158 Article
• 24 Review article
• 20 Meeting abstract
• 6 Letter
• 19 More
  • 5 Book
  • 4 Chapter
  • 3 Comment/debate
  • 3 Doctoral Thesis
  • 1 Paper
  • 1 Poster
  • 1 Editorial
  • 1 Short survey

Research output per year

Research output per year

Search results

• 2020

  Abstract 2525: Identification of mRNA targets associated with PIWIL1 protein complex in lung cancer cells

  Amaar, Y. G. & Reeves, M. E., Aug 15 2020, In: Cancer Research. 80, 16_Supplement, p. 2525-2525 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2019

  Abstract 5304: Gem-interacting protein (Gmip) is potentially a new lung tumor suppressor

  Amaar, Y. G. & Reeves, M. E., Jul 1 2019, In: Cancer Research. 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2018

  166P Evidence-based conclusions and indinations of pemetrexed, taxane and bevacizumab in advanced lung cancer

  Shaheen, S., Ji, L., Morgan, J. W., Otoukesh, S. & Mirshahidi, H. R., Apr 1 2018, In: Journal of Thoracic Oncology. 13

  Research output: Contribution to journal › Meeting abstract › peer-review

• Abstract 365: The impact of the RASSF1C-PIWIL1-piRNA pathway on DNA methylation

  Amaar, Y. G. & Reeves, M. E., Jul 1 2018, In: Cancer Research. 78, 13_Supplement, p. 365-365 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Abstract P6-10-04: “Disparities in breast cancer: A multi-institutional comparative analysis focusing on American Hispanics”

  Otoukesh, S., Nahleh, Z., Mirshahidi, H. R., Nguyen, A., Botrus, G., Badri, N., Diab, N., Alvarado, A., Sanchez, L. & Dwivedi, A., Feb 15 2018, In: Cancer Research. 78, 4_Supplement, p. P6-10-04-P6-10-04

  Research output: Contribution to journal › Meeting abstract › peer-review

• EGFR reporting in stage IV adenocarcinoma of the lung: Demographic predictors of EGFR testing and survival.

  Shaheen, S., Ji, L., Mirshahidi, H. R., Otoukesh, S., Nagaraj, G., Mirshahidi, S. & Morgan, J. W., May 20 2018, In: Journal of Clinical Oncology. 36, 15_suppl, p. 9100-9100 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2017

  PS01.03 Reduced Length of Stay and Financial Burden, but Comparable Outcomes : VATS VS Open Thoracotomy in Resectable Lung Cancer: Topic: Surgery

  Shaheen, S., Jabo, B., Kaur, M., Mirshahidi, S. & Mirshahidi, H. R., Nov 1 2017, In: Journal of Thoracic Oncology. 12, 11, p. S1561-S1562

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2015

  Abstract 1828: Proteomic analysis of the effect of E6 star expression on cellular pathways in HPV positive SiHa and HPV negative C33A cervical carcinoma cells

  Evans, W., Filippova, M., Aragon, R., Filippov, V., Reeves, M. E. & Duerksen-Hughes, P. J., Aug 1 2015, In: Cancer Research. 75, 15_Supplement, p. 1828-1828 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Abstract 2146: RASSF1C modulation of Piwi-interacting RNAs (piRNAs) in lung cancer

  Amaar, Y. G., Firek, M. & Reeves, M. E., Aug 1 2015, In: Cancer Research. 75, 15_Supplement, p. 2146-2146 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Abstract P3-11-16: S0800: Nab-paclitaxel, doxorubicin, cyclophosphamide, and pegfilgrastim with or without bevacizumab in treating women with inflammatory or locally advanced breast cancer (NCI CDR0000636131)

  Nahleh, Z. A., Barlow, W. E., Hayes, D. F., Schott, A. F., Gralow, J. R., Perez, E. A., Sikov, W. M., Chennuru, S., Mirshahidi, H. R., Vidito, S., Lew, D. L., Pusztai, L., Livingston, R. B. & Hortobagyi, G. N., May 1 2015, In: Cancer Research. 75, 9_Supplement, p. P3-11-16-P3-11-16

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2014

  Abstract 2454: Ampk and hdac pathways and regulation rassf1c gene expression

  Amaar, Y. G., Reeves, M. E. & Firek, M., Oct 1 2014, In: Cancer Research. 74, 19_Supplement, p. 2454-2454 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2013

  Abstract 4288: RASSF1C, unlike RASSF1A, reduces TNF-α induced phosphorylation of MST1/2.

  Amaar, Y. G., Firek, M. & Reeves, M. E., Apr 15 2013, In: Cancer Research. 73, 8_Supplement, p. 4288-4288 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2012

  Abstract 2663: Phase I study of azacitidine and cisplatin in patients with advanced head and neck or non-small cell lung cancer

  Liao, Y.-M., Mirshahidi, H. R., Zhang, K., Mirshahidi, S., Williamson, S. & Hsueh, C.-T., Apr 15 2012, In: Cancer Research. 72, 8_Supplement, p. 2663-2663 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2011

  Abstract 1139: Ras association domain family protein 1, isoform C (RASSF1C) promotes breast tumor growthin vivo

  Reeves, M. E., Aragon, R. J., Alfakouri, M., Chen, S.-T. & Amaar, Y. G., Apr 15 2011, In: Cancer Research. 71, 8_Supplement, p. 1139-1139 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Abstract A78: Cancer in Hinkley: What was the real problem?

  Morgan, J. W. & Reeves, M. E., Sep 1 2011, In: Cancer Epidemiology, Biomarkers Prevention. 20, 10_Supplement, p. A78-A78

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2010

  (P062) LAPAROSOPIC INTRACORPOREAL SUTURING COMPETENCE AMONG RESIDENTS: CAN WE PREDICT SUCCESS?

  Baerg, J. E., Michelotti, M., Tamez, A. J. & Reeves, M. E., May 22 2010, In: Journal of Laparoendoscopic Advanced Surgical Techniques. 20, S1

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2008

  PDGFR inhibition using imatinib (I) combined with docetaxel (D), a potential new treatment strategy in the treatment of recurrent non-small cell lung cancer (NSCLC): Preliminary efficacy results

  Huang, C. H., Williamson, S. K., VanVeldhuizen, P. J., Hsueh, C. T., Allen, A., Smith, H., Mayo, M., Tawfik, O., Uypeckcuat, A. M. & Kelly, K., May 20 2008, In: Journal of Clinical Oncology. 26, 15_suppl, p. 19055-19055 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Phase I/II study of AT-101 in combination with topotecan in patients with relapsed or refractory small cell lung cancer after prior platinum containing first line chemotherapy

  Heist, R. S., Molina, J. R., Urba, W. J., Mirshahidi, H. R., Grunberg, S., Maleski, J., Brainerd, V., Leopold, L. & Lynch, T. J., May 20 2008, In: Journal of Clinical Oncology. 26, 15_suppl, p. 19004-19004 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2007

  Phase II trial of imatinib (I) and docetaxel (D) in recurrent non-small cell lung cancer (NSCLC)

  Huang, C. H., Williamson, S., Van Veldhuizen, P. J., Hsueh, C. T., Smith, H., Mayo, M., Allen, A. & Kelly, K., Jun 20 2007, In: Journal of Clinical Oncology. 25, 18_suppl, p. 18132-18132 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2005

  Effects of celecoxib on vascular endothelial growth factor (VEGF) gene expression in squamous cell carcinoma of head and neck (SCCHN) patients receiving 5-fluorouracil and cisplatin

  Hsueh, C.-T., Chiu, C.-F., Yeh, S.-P. & Liao, Y.-M., Jun 1 2005, In: Journal of Clinical Oncology. 23, 16_suppl, p. 5603-5603 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review